The expansion builds on the company’s existing physician-facing solution, now incorporating the BluePrint application. Originally developed at the University of Michigan, BluePrint standardizes treatment planning from initial intent through final approval. By housing these disparate roles within a single environment, Fuse aims to eliminate the redundant manual entries that currently stall clinical progress.
In section Releases
Fuse Oncology Scales Radiation Workflow Platform Beyond Physicians
Patients often endure month-long waits between initial oncology consultations and their first radiation treatments. Fuse Oncology is moving to close that gap by expanding its FuseRx platform, integrating physicists, dosimetrists, therapists, and nurses into a unified digital workflow designed to replace fragmented communication methods like faxes and PDFs.
This integrated approach draws from real-world performance at Cone Health, a Risant Health facility. Prototype testing at the site demonstrated a significant reduction in wait times, bringing the interval from consultation to treatment down to 3.4 days. Beyond efficiency, the model achieved high marks in staff engagement and patient satisfaction scores. Fuse Oncology will showcase these role-specific workflows at the upcoming ASTRO 2026 Annual Meeting in Boston.
Comments (0)
No comments yet. Be the first!